Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
13 Leser
Artikel bewerten:
(0)

Hanger Orthopedic Group, Inc. Reports $0.16 EPS on 16% Increase in Proforma Net Income for the First Quarter 2010

BETHESDA, Md., April 26 /PRNewswire/ -- Hanger Orthopedic Group, Inc. announced net sales of $178.3 million for the quarter ended March 31, 2010, an increase of $9.2 million, or 5.4%, from $169.1 million in the prior year. Earnings per share, excluding the costs related to the relocation of the Company's corporate headquarters, for the first quarter of 2010 were $0.16 per diluted share compared to $0.14 per diluted share for the same period in 2009. Reported diluted earnings per share, including the costs of relocating the corporate headquarters, were $0.12 for the first quarter of 2010.

The $9.2 million, or 5.4%, sales increase for the quarter ended March 31, 2010 was primarily the result of a $5.4 million, or 3.6%, increase in same-center sales in the patient care segment, a $0.9 million, or 4.3%, increase in sales from the Company's distribution segment and a $2.9 million increase principally related to sales from acquired entities. Income from operations for the quarter ended March 31, 2010 was $14.2 million compared to $15.1 million in the prior year. Excluding the $2.1 million of costs related to the relocation of the corporate office, income from operations increased 7.5% to $16.3 million due to the growth in sales and continued expense management efforts. Proforma income from operations as a percentage of sales improved 20 basis points to 9.1% in 2010 compared to 8.9% in 2009.

The Company used $12.1 million in cash in the first quarter of 2010 which was $8.4 million more than the $3.7 million used in 2009 to fund normal working capital needs. The Company had total liquidity of $127.6 million, comprised of $64.1 million of cash and $63.5 million available under its revolving credit facility at March 31, 2010.

"I am pleased that we opened 2010 with a very positive fashion," commented Thomas F. Kirk, President and Chief Executive Officer of Hanger Orthopedic Group. Mr. Kirk added, "Our patient care segment performed well posting a 3.6% same store increase and we continue to see positive results from our other growth initiatives. The increased revenue combined with our expense management generated 7.5% increase in operating income and a 20 basis point improvement in operating margin. I want to thank our employees for their hard work and their continued dedication to our patients' and customers' needs."

For 2010, the Company expects full year revenues to be between $815 million and $825 million and diluted EPS, excluding cost related to the corporate relocation, in the range of $1.27 to $1.29. As announced in February, the Company is in the process of relocating its corporate headquarters from Bethesda, Maryland to Austin, Texas and anticipates the move will be substantially completed by the end of the third quarter of 2010. The cost of this move is reported as a separate component of income from operations. In connection with the move the Company reported $2.1 million of severance and relocation cost for the three months ended March 31, 2010. The Company anticipates incurring approximately $8.0 million to $10.0 million of additional severance and relocation cost through the third quarter of 2010, as well as lease exit cost of approximately $3.0 million to $5.0 million. Once complete, the Company anticipates that the move will result in a reduction of operating expenses of approximately $2.5 million to $3.5 million annually.

Hanger Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the world's premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating 678 patient care centers in 45 states and the District of Columbia, with over 3,700 employees, including 1,110 practitioners, as of March 31, 2010. Hanger is organized into four units. The two key operating units are patient care, which consists of nationwide orthotic and prosthetic practice centers, and distribution, which consists of distribution centers managing the supply chain of orthotic and prosthetic componentry to Hanger and third party patient care centers. The third is Linkia, which is the first and only provider network management company for the orthotics and prosthetics industry. The fourth unit, Innovative Neurotronics, introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide. For more information on Innovative Neurotronics, Inc. or the WalkAide®, visit http://www.ininc.us/. For more information on Hanger, visit http://www.hanger.com/.

This document contains forward-looking statements relating to the Company's results of operations. The United States Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for certain forward-looking statements. Statements relating to future results of operations in this document reflect the current views of management. However, various risks, uncertainties and contingencies could cause actual results or performance to differ materially from those expressed in, or implied by, these statements, including the Company's ability to enter into and derive benefits from managed care contracts, the demand for the Company's orthotic and prosthetic services and products and the other factors identified in the Company's periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934. The Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

-tables to follow- Hanger Orthopedic Group, Inc (Dollars in thousands, except for share and per share amounts) (Unaudited) Three Months Ended March 31, Income Statement: 2010 2009 ----------------- ---- ---- Net sales $178,316 $169,146 Cost of goods sold - materials 53,650 51,049 Personnel costs 68,769 64,059 Other operating expenses 35,315 34,451 Relocation expenses 2,059 - Depreciation and amortization 4,311 4,456 ----- ----- Income from operations 14,212 15,131 Interest expense 7,542 7,607 ----- ----- Income before taxes 6,670 7,524 Provision for income taxes 2,668 3,009 ----- ----- Net income $4,002 $4,515 ====== ====== Basic Per Common Share Data: ----------------------------- Net income $0.13 $0.15 ===== ===== Shares used to compute basic per common share amounts 31,881,750 30,926,725 ========== ========== Diluted Per Common Share Data: ------------------------------ Net income $0.12 $0.14 ===== ===== Shares used to compute diluted per common share amounts 32,926,033 31,955,851 ========== ========== Pro-forma: ---------- Net income 4,002 4,515 Relocation expenses, net of tax 1,235 - Pro-forma net income $5,237 $4,515 ====== ====== Diluted Per Share Data: ----------------------- Pro-forma net income per diluted common share $0.16 $0.14 ===== ===== Three Months Ended March 31, Income Statement as a % of Net Sales: 2010 2009 -------------------------- ---- ---- Net sales 100.0% 100.0% Cost of goods sold - materials 30.1% 30.2% Personnel costs 38.6% 37.9% Other operating expenses 19.8% 20.4% Relocation expenses 1.2% 0.0% Depreciation and amortization 2.4% 2.6% --- --- Income from operations 7.9% 8.9% Interest expense 4.2% 4.5% --- --- Income before taxes 3.7% 4.4% Provision for income taxes 1.5% 1.8% --- --- Net income 2.2% 2.6% === === Hanger Orthopedic Group, Inc (Dollars in thousands, except for share and per share amounts) (Unaudited) Three Months Ended March 31, Cash Flow Data: 2010 2009 --------------- ---- ---- Cash flow used in operations $(12,073) $(3,716) Capital expenditures $7,914 $2,827 Decrease in cash $(20,492) $(6,480) Mar. 31, Dec. 31, Balance Sheet Data: 2010 2009 ------------------- --------- --------- Cash and cash equivalents $64,066 $84,558 Days Sales Outstanding (DSO's) 46 50 Working Capital $223,242 $216,664 Total Debt $408,762 $410,472 Shareholders' Equity $324,260 $315,893 Three Months Ended March 31, Percentage of net sales from: 2010 2009 ---- ---- Patient-care services 87.5% 87.4% Distribution 12.2% 12.4% Payor mix: Commercial and other 59.4% 58.6% Medicare 28.3% 30.3% Medicaid 6.8% 5.9% VA 5.5% 5.2% Three Months Statistical Data: Ended ----------------- March 31, 2010 2009 ---- ---- Patient-care centers 678 675 Number of practitioners 1,110 1,083 Number of states (including D.C.) 46 46

Hanger Orthopedic Group, Inc.

CONTACT: Thomas F. Kirk, +1-301-986-0701, George E. McHenry,
+1-301-986-0701, or Thomas C. Hofmeister, +1-301-986-0701

Web Site: http://www.hanger.com/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.